SGMT · Sagimet Biosciences
AI read · Neutral
The AI's read
An analyst's unchanged view does not show that Sagimet's results or plans changed. The report gives no new company details, so it adds no reason to change how we read the business.
Canaccord Genuity still thinks Sagimet Biosciences is a good buy.
Neutral
Sagimet Biosciences kept Canaccord Genuity's Buy rating, but the report lists no new company results or changes. It adds no new information about the business.
Get alerts for SGMT
Follow Sagimet Biosciences (SGMT) free. When we publish a story about it, you get the plain-English explanation as an alert.
Get alerts for SGMTFree on the App Store and Google Play, or on the web.